All patients gave their informed consent before enlisting in the study. In addition to the diagnosis of dry eye, patients eligible for the study were required to have a rose bengal score of greater than 3 (on a scale of 0 to 21). This was to exclude very mild cases where statistical comparisons of staining scores would not be possible. Patients with infectious extraocular disease, corneal epithelial disorders associated with diabetes mellitus, and neurotrophic keratitis were excluded from the study. Patients with overt asymmetrical staining patterns at the time of initial examination were also excluded.
The test medication used was a preservativefree 0 1% sodium hyaluronate solution (1 X 106 Da) bottled in a single dose disposable container. The vehicle for the solution, consisting of the same agents as the test solution excluding sodium hyaluronate (25 mM phosphate buffered saline, pH 7 36), was used as control. Identical disposable containers were used so that discrimination between solutions was difficult.
The study was conducted in a double blind, controlled fashion in which each patient received the sodium hyaluronate eyedrops in one eye, and the vehicle in the other. The eye to receive sodium hyaluronate in each patient was randomly selected by a designated study controller.
Before participating in the study, patients were required to 'wash out' their eyes for 2 weeks with a conventional preservative-free artificial tear solution (Soft Santear, an isotonic NaCl, KCI solution with 1% boric acid, pH 7-0-8-0, Santen Pharmaceuticals, Osaka Japan), applied six times a day. After this 2 week period, patients were examined and interviewed to grade subjective symptoms such as foreign body sensation, pain, burning, and itching on a scale of 0 to 5 (see Table 1 for list of symptoms). Fluorescein and rose bengal staining, as well as tear break up time were observed according to Toda and Tsubotal3 by instilling 2 ,ul of a 1% fluorescein-1% rose bengal solution by micropipette (Fig 1) . Micropipettes were used in order to obtain Figure 3 . The time required for 50% recovery in erosion size was significantly shorter in groups receiving 01% and 0 5°/ sodium hyaluronate (18 hours) compared with the untreated group, or the group receiving vehicle alone (30 hours). The accelerating effect of sodium hyaluronate was observed up to 22 hours after erosion of the epithelium. Between 22 hours and 34 hours, the healing rates in each group were similar, but wound area was significantly smaller in both concentrations of sodium hyaluronate compared with control and the untreated group. No significant difference was observed between 0-1% and 0 5% sodium hyaluronate in both healing rate and wound area, and therefore 01% was chosen as the final concentration to be used in the clinical trial.
CLINICAL STUDY
Of the 104 patients enrolled in the study, 91 patients successfully completed the trial and were eligible for statistical analysis. Among the 13 dropout patients, two patients developed signs of allergic conjunctivitis, one discontinued treatment because of exacerbation of symptoms, and the remainder were disqualified because of non-compliance of dose or period not related to symptoms or side effects. Non-compliance was mainly the result of a lack of understanding of the protocol such as omitting to apply drops, or failure to visit clinics on the appointed dates. Compliance of dose was confirmed by counting the number of empty and untouched containers collected at each visit.
No statistically significant difference was observed between any of the subjective symptoms under study in terms of improvement in grading scores (Table 1 ). There was a trend towards improvement in blurring of vision in eyes receiving sodium hyaluronate (p=0.063).
The absolute score value for foreign body sensation at 4 weeks was less in sodium Time following exposure to iodine vapour (hours) Figure 3 Wound size (mean (SD) Previous reports have demonstrated improvements in rose bengal staining with the use of sodium hyaluronate drops.2 5 6 This discrepancy with our results may be due to differences in scoring methods, the manner in which dyes were applied, or the number of patients involved. Certain limitations in our study design can also be pointed out. Different climatic conditions among the eight centres may have contributed to variability. Although outpatient clinics were all run during the morning, variation in the interval between clinical evaluation and the last drop applied may have affected results. However, the relatively large number of patients (n= 104) enrolled in this double blind study, excellent patient compliance, and the use of micropipettes to apply precise amounts of dye have assured maximal standardisation in such a clinical situation.
Sodium hyaluronate drops presented with very few complications. Two patients developed signs of allergic conjunctivitis, and only one patient had to discontinue the trial owing to exacerbation of symptoms. This patient was treated with her original prescription of frequently applied tear supplies to alleviate symptoms.
Sodium hyaluronate drops alone in six daily doses may not adequately improve subjective symptoms associated with dry eye, but may play a role in maintaining a healthy corneal epithelium. Drops applied more frequently, or in conjunction with conventional tear replacements, may offer effective treatment of patients with dry eyes.
